ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Somatropin for Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30I15578
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Somatropin for Injection Market Research Report 2023
BUY CHAPTERS

Global Recombinant Human Somatropin for Injection Market Research Report 2025

Code: QYRE-Auto-30I15578
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
LG Chem
Pfizer Inc
Eli Lilly
Merck
Roche
Changchun GeneScience Pharmaceutical
Anhui Anke Biotechnology
Shanghai United Cell Biotechnology
Zhongshan Sinobioway Hygene Biomedicine

Recombinant Human Somatropin for Injection Market Size

The global market for Recombinant Human Somatropin for Injection was valued at US$ 2578 million in the year 2024 and is projected to reach a revised size of US$ 3291 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Recombinant Human Somatropin for Injection Market

Recombinant Human Somatropin for Injection Market

Recombinant Human Somatropin, commonly known as somatropin or human growth hormone (hGH), is a synthetic form of the growth hormone produced naturally in the human body. Somatropin is created using recombinant DNA technology, and it is structurally identical to the growth hormone secreted by the pituitary gland. It is used for various medical and non-medical purposes.
Recombinant Human Somatropin for Injection is a widely used biopharmaceutical in the medical field, primarily employed in the treatment of growth hormone deficiency, short stature, muscle wasting, and related conditions. The market size is substantial, driven by ongoing concerns related to endocrine and growth issues in both children and adults. Sales of the product have steadily increased over the years and are expected to continue to show potential in the future, particularly with the introduction of new therapeutic applications and improved delivery methods, such as enhanced injection devices. Furthermore, as medical science and technology continue to advance, recombinant human somatropin may find applications in a broader spectrum of health fields, creating more opportunities for its future development.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Somatropin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Somatropin for Injection.
The Recombinant Human Somatropin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Somatropin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Somatropin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Somatropin for Injection Market Report

Report Metric Details
Report Name Recombinant Human Somatropin for Injection Market
Accounted market size in year US$ 2578 million
Forecasted market size in 2031 US$ 3291 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck, Roche, Changchun GeneScience Pharmaceutical, Anhui Anke Biotechnology, Shanghai United Cell Biotechnology, Zhongshan Sinobioway Hygene Biomedicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Somatropin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Somatropin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Human Somatropin for Injection Market growing?

Ans: The Recombinant Human Somatropin for Injection Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Recombinant Human Somatropin for Injection Market size in 2031?

Ans: The Recombinant Human Somatropin for Injection Market size in 2031 will be US$ 3291 million.

Who are the main players in the Recombinant Human Somatropin for Injection Market report?

Ans: The main players in the Recombinant Human Somatropin for Injection Market are Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck, Roche, Changchun GeneScience Pharmaceutical, Anhui Anke Biotechnology, Shanghai United Cell Biotechnology, Zhongshan Sinobioway Hygene Biomedicine

What are the Application segmentation covered in the Recombinant Human Somatropin for Injection Market report?

Ans: The Applications covered in the Recombinant Human Somatropin for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Recombinant Human Somatropin for Injection Market report?

Ans: The Types covered in the Recombinant Human Somatropin for Injection Market report are Powder Injection, Aqueous Injection

Recommended Reports

Growth Hormone Therapies

Recombinant Injectables

Pituitary & Endocrine

1 Recombinant Human Somatropin for Injection Market Overview
1.1 Product Definition
1.2 Recombinant Human Somatropin for Injection by Type
1.2.1 Global Recombinant Human Somatropin for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder Injection
1.2.3 Aqueous Injection
1.3 Recombinant Human Somatropin for Injection by Application
1.3.1 Global Recombinant Human Somatropin for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Human Somatropin for Injection Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Somatropin for Injection Revenue 2020-2031
1.4.2 Global Recombinant Human Somatropin for Injection Sales 2020-2031
1.4.3 Global Recombinant Human Somatropin for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Somatropin for Injection Market Competition by Manufacturers
2.1 Global Recombinant Human Somatropin for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Somatropin for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Somatropin for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Somatropin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Somatropin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Somatropin for Injection, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Somatropin for Injection, Date of Enter into This Industry
2.8 Global Recombinant Human Somatropin for Injection Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Somatropin for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Somatropin for Injection Players Market Share by Revenue
2.8.3 Global Recombinant Human Somatropin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Somatropin for Injection Market Scenario by Region
3.1 Global Recombinant Human Somatropin for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Somatropin for Injection Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Somatropin for Injection Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Somatropin for Injection Sales by Region: 2026-2031
3.3 Global Recombinant Human Somatropin for Injection Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Somatropin for Injection Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Somatropin for Injection Revenue by Region: 2026-2031
3.4 North America Recombinant Human Somatropin for Injection Market Facts & Figures by Country
3.4.1 North America Recombinant Human Somatropin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Somatropin for Injection Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Somatropin for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Somatropin for Injection Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Somatropin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Somatropin for Injection Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Somatropin for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Somatropin for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Somatropin for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Somatropin for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Somatropin for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Somatropin for Injection Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Somatropin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Somatropin for Injection Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Somatropin for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Somatropin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Somatropin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Somatropin for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Somatropin for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Somatropin for Injection Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Somatropin for Injection Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Somatropin for Injection Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Somatropin for Injection Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Somatropin for Injection Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Somatropin for Injection Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Somatropin for Injection Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Somatropin for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Somatropin for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Somatropin for Injection Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Somatropin for Injection Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Somatropin for Injection Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Somatropin for Injection Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Somatropin for Injection Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Somatropin for Injection Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Somatropin for Injection Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Somatropin for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Somatropin for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Recombinant Human Somatropin for Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 LG Chem
6.2.1 LG Chem Company Information
6.2.2 LG Chem Description and Business Overview
6.2.3 LG Chem Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LG Chem Recombinant Human Somatropin for Injection Product Portfolio
6.2.5 LG Chem Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Recombinant Human Somatropin for Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Eli lilly
6.4.1 Eli lilly Company Information
6.4.2 Eli lilly Description and Business Overview
6.4.3 Eli lilly Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli lilly Recombinant Human Somatropin for Injection Product Portfolio
6.4.5 Eli lilly Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Recombinant Human Somatropin for Injection Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Roche
6.6.1 Roche Company Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche Recombinant Human Somatropin for Injection Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Changchun GeneScience Pharmaceutical
6.7.1 Changchun GeneScience Pharmaceutical Company Information
6.7.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.7.3 Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Product Portfolio
6.7.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.8 Anhui Anke Biotechnology
6.8.1 Anhui Anke Biotechnology Company Information
6.8.2 Anhui Anke Biotechnology Description and Business Overview
6.8.3 Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Product Portfolio
6.8.5 Anhui Anke Biotechnology Recent Developments/Updates
6.9 Shanghai United Cell Biotechnology
6.9.1 Shanghai United Cell Biotechnology Company Information
6.9.2 Shanghai United Cell Biotechnology Description and Business Overview
6.9.3 Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Product Portfolio
6.9.5 Shanghai United Cell Biotechnology Recent Developments/Updates
6.10 Zhongshan Sinobioway Hygene Biomedicine
6.10.1 Zhongshan Sinobioway Hygene Biomedicine Company Information
6.10.2 Zhongshan Sinobioway Hygene Biomedicine Description and Business Overview
6.10.3 Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Product Portfolio
6.10.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Somatropin for Injection Industry Chain Analysis
7.2 Recombinant Human Somatropin for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Somatropin for Injection Production Mode & Process Analysis
7.4 Recombinant Human Somatropin for Injection Sales and Marketing
7.4.1 Recombinant Human Somatropin for Injection Sales Channels
7.4.2 Recombinant Human Somatropin for Injection Distributors
7.5 Recombinant Human Somatropin for Injection Customer Analysis
8 Recombinant Human Somatropin for Injection Market Dynamics
8.1 Recombinant Human Somatropin for Injection Industry Trends
8.2 Recombinant Human Somatropin for Injection Market Drivers
8.3 Recombinant Human Somatropin for Injection Market Challenges
8.4 Recombinant Human Somatropin for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
LG Chem
Pfizer Inc
Eli Lilly
Merck
Roche
Changchun GeneScience Pharmaceutical
Anhui Anke Biotechnology
Shanghai United Cell Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
List of Tables
 Table 1. Global Recombinant Human Somatropin for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Somatropin for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Somatropin for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Somatropin for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Somatropin for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Somatropin for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Somatropin for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Somatropin for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Somatropin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Somatropin for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Somatropin for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Somatropin for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Somatropin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Somatropin for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Somatropin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Somatropin for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human Somatropin for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Somatropin for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human Somatropin for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Somatropin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Somatropin for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Somatropin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Somatropin for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Somatropin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Somatropin for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human Somatropin for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human Somatropin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Somatropin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Somatropin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Somatropin for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human Somatropin for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human Somatropin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Somatropin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Somatropin for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Somatropin for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human Somatropin for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human Somatropin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Somatropin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Somatropin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Somatropin for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human Somatropin for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human Somatropin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Somatropin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Somatropin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Somatropin for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human Somatropin for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human Somatropin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Somatropin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Somatropin for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human Somatropin for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human Somatropin for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Somatropin for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Somatropin for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Somatropin for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Somatropin for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Somatropin for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Somatropin for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human Somatropin for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human Somatropin for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human Somatropin for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human Somatropin for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Somatropin for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Somatropin for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Somatropin for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Somatropin for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Somatropin for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Somatropin for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human Somatropin for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Recombinant Human Somatropin for Injection Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. LG Chem Company Information
 Table 76. LG Chem Description and Business Overview
 Table 77. LG Chem Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. LG Chem Recombinant Human Somatropin for Injection Product
 Table 79. LG Chem Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Recombinant Human Somatropin for Injection Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Eli lilly Company Information
 Table 86. Eli lilly Description and Business Overview
 Table 87. Eli lilly Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Eli lilly Recombinant Human Somatropin for Injection Product
 Table 89. Eli lilly Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Recombinant Human Somatropin for Injection Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Roche Company Information
 Table 96. Roche Description and Business Overview
 Table 97. Roche Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Roche Recombinant Human Somatropin for Injection Product
 Table 99. Roche Recent Developments/Updates
 Table 100. Changchun GeneScience Pharmaceutical Company Information
 Table 101. Changchun GeneScience Pharmaceutical Description and Business Overview
 Table 102. Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Product
 Table 104. Changchun GeneScience Pharmaceutical Recent Developments/Updates
 Table 105. Anhui Anke Biotechnology Company Information
 Table 106. Anhui Anke Biotechnology Description and Business Overview
 Table 107. Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Product
 Table 109. Anhui Anke Biotechnology Recent Developments/Updates
 Table 110. Shanghai United Cell Biotechnology Company Information
 Table 111. Shanghai United Cell Biotechnology Description and Business Overview
 Table 112. Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Product
 Table 114. Shanghai United Cell Biotechnology Recent Developments/Updates
 Table 115. Zhongshan Sinobioway Hygene Biomedicine Company Information
 Table 116. Zhongshan Sinobioway Hygene Biomedicine Description and Business Overview
 Table 117. Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Product
 Table 119. Zhongshan Sinobioway Hygene Biomedicine Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Recombinant Human Somatropin for Injection Distributors List
 Table 123. Recombinant Human Somatropin for Injection Customers List
 Table 124. Recombinant Human Somatropin for Injection Market Trends
 Table 125. Recombinant Human Somatropin for Injection Market Drivers
 Table 126. Recombinant Human Somatropin for Injection Market Challenges
 Table 127. Recombinant Human Somatropin for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Somatropin for Injection
 Figure 2. Global Recombinant Human Somatropin for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Somatropin for Injection Market Share by Type: 2024 & 2031
 Figure 4. Powder Injection Product Picture
 Figure 5. Aqueous Injection Product Picture
 Figure 6. Global Recombinant Human Somatropin for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Human Somatropin for Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global Recombinant Human Somatropin for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Human Somatropin for Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Human Somatropin for Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Human Somatropin for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Human Somatropin for Injection Report Years Considered
 Figure 16. Recombinant Human Somatropin for Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Human Somatropin for Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Human Somatropin for Injection Players: Market Share by Revenue in Recombinant Human Somatropin for Injection in 2024
 Figure 19. Recombinant Human Somatropin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Human Somatropin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Human Somatropin for Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Human Somatropin for Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Human Somatropin for Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Human Somatropin for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Human Somatropin for Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Human Somatropin for Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Recombinant Human Somatropin for Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Recombinant Human Somatropin for Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Recombinant Human Somatropin for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Recombinant Human Somatropin for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Recombinant Human Somatropin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Recombinant Human Somatropin for Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Recombinant Human Somatropin for Injection by Type (2020-2031)
 Figure 53. Global Recombinant Human Somatropin for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Recombinant Human Somatropin for Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Human Somatropin for Injection by Application (2020-2031)
 Figure 56. Global Recombinant Human Somatropin for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Recombinant Human Somatropin for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Recombinant Growth Hormone Market Research Report 2024
Global Recombinant Human Growth Hormone Market Research Report 2025
Global Synthetic Human Growth Hormone Market Insights Forecast to 2030
Global Human Growth Hormone Market Research Report 2025
Human Growth Hormone Treatment and Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Growth Hormone Injection Market Research Report 2024
Global Recombinant Human Growth Hormone Injections Market Research Report 2024
Global Pediatric Growth Hormone Market Research Report 2025
Human Growth Hormone Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Hormone Market Research Report 2024
Recombinant Human Follicle stimulating Hormone Market
Recombinant Human Parathyroid Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Chorionic Gonadotropin HCG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Somatostatin for Injection Market Research Report 2024
Human Growth Hormone for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prefilled Human Growth Hormone Injection Market Research Report 2024
Global Manmade Version of Somatostatin Market Research Report 2024
Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Insulin Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions